Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors

Details for Australian Patent Application No. 2005321903 (hide)

Owner Memory Pharmaceuticals Corp.

Inventors Hopper, Allen; Arrington, Mark Phillip; Liu, Ruiping; Tehim, Ashok

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005321903

PCT Pub. Number WO2006/071988

Priority 60/638,179 23.12.04 US

Filing date 27 December 2005

Wipo publication date 6 July 2006

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/071988 Priority application(s): WO2006/071988

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321904-Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes

2005321898-Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines